TY  - JOUR

T1  - 64775 Integrated Safety Update of Abrocitinib in 1014 Young Adult Patients Aged 18 to <40 Years With Moderate-to-Severe Atopic Dermatitis: Data From More Than 2250 Patient-Years With up to 4.5 Years of Exposure

JO  - Journal of the American Academy of Dermatology

PY  - 2025/09/01

AU  - Simpson E

AU  - Irvine AD

AU  - Silverberg JI

AU  - Gold LFS

AU  - Cork MJ

AU  - Deleuran M

AU  - Geng B

AU  - Lumpan C

AU  - Selfridge A

AU  - Fan H

AU  - Koppensteiner H

ED  - 

DO  - DOI: 10.1016/j.jaad.2025.05.928

PB  - Elsevier

VL  - 93

IS  - 3

SP  - ab234

Y2  - 2025/09/17

ER  -